tiprankstipranks
Arecor Therapeutics PLC (GB:AREC)
LSE:AREC
UK Market
AREC
Arecor Therapeutics PLC
RESEARCH TOOLSreports
Want to see GB:AREC full AI Analyst Report?

Arecor Therapeutics PLC (AREC) Ratios

6 Followers

Arecor Therapeutics PLC Ratios

GB:AREC's free cash flow for Q4 2025 was £-2.50. For the 2025 fiscal year, GB:AREC's free cash flow was decreased by £ and operating cash flow was £7.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.35 4.35 2.53 2.17 4.69
Quick Ratio
 4.35 4.35 2.38 2.02 4.38
Cash Ratio
 1.86 1.86 0.99 0.99 1.28
Solvency Ratio
 0.53 0.53 -2.90 -1.38 -2.07
Operating Cash Flow Ratio
 -1.42 -1.42 -2.81 -1.13 -2.89
Short-Term Operating Cash Flow Coverage
 -23.85 -23.85 -75.66 -49.50 -53.37
Net Current Asset Value
£ 5.35M£ 5.35M£ 4.86M£ 5.32M£ 13.17M
Leverage Ratios
Debt-to-Assets Ratio
 0.01 0.01 0.03 0.02 0.01
Debt-to-Equity Ratio
 0.02 0.02 0.04 0.04 0.02
Debt-to-Capital Ratio
 0.01 0.01 0.04 0.03 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.26 1.26 1.63 1.61 1.25
Debt Service Coverage Ratio
 -41.58 -41.58 -68.31 -60.47 -39.37
Interest Coverage Ratio
 -418.36 -418.36 -486.23 -611.67 -555.24
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 0.01 0.01
Net Debt to EBITDA
 0.66 0.66 0.30 0.57 0.44
Profitability Margins
Gross Profit Margin
61.32%61.32%30.54%100.00%100.00%
EBIT Margin
-268.49%-268.49%-209.70%-194.31%-432.92%
EBITDA Margin
-255.95%-255.95%-200.87%-183.47%-418.73%
Operating Profit Margin
-268.49%-268.49%-211.70%-200.63%-485.23%
Pretax Profit Margin
57.99%57.99%-210.13%-194.64%-438.70%
Net Profit Margin
38.74%38.74%-202.57%-187.05%-385.35%
Continuous Operations Profit Margin
54.38%54.38%-202.57%-187.05%-385.35%
Net Income Per EBT
66.80%66.80%96.40%96.10%87.84%
EBT Per EBIT
-21.60%-21.60%99.26%97.01%90.41%
Return on Assets (ROA)
8.20%8.20%-117.36%-55.63%-42.55%
Return on Equity (ROE)
14.26%10.29%-191.36%-89.79%-53.05%
Return on Capital Employed (ROCE)
-70.90%-70.90%-195.70%-89.71%-64.64%
Return on Invested Capital (ROIC)
-65.51%-65.51%-180.66%-84.27%-55.54%
Return on Tangible Assets
8.21%8.21%-117.80%-70.81%-50.43%
Earnings Yield
2.66%2.18%-41.65%-15.31%-13.33%
Efficiency Ratios
Receivables Turnover
 1.97 1.97 1.76 1.60 3.62
Payables Turnover
 0.47 0.47 4.19 1.48 0.20
Inventory Turnover
 0.00 0.00 7.34 4.31 0.30
Fixed Asset Turnover
 5.75 5.75 12.63 5.48 2.87
Asset Turnover
 0.21 0.21 0.58 0.30 0.11
Working Capital Turnover Ratio
 0.44 0.33 0.92 0.46 0.15
Cash Conversion Cycle
 -594.15 -594.15 170.17 66.69 -517.82
Days of Sales Outstanding
 184.84 184.84 207.60 228.75 100.86
Days of Inventory Outstanding
 0.00 0.00 49.71 84.71 1.21K
Days of Payables Outstanding
 779.00 779.00 87.14 246.78 1.83K
Operating Cycle
 184.84 184.84 257.31 313.47 1.31K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.06 -0.06 -0.27 -0.19 -0.37
Free Cash Flow Per Share
 -0.06 -0.06 -0.27 -0.20 -0.38
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 0.01
Free Cash Flow to Operating Cash Flow
 1.04 1.04 1.00 1.03 1.03
Dividend Paid and CapEx Coverage Ratio
 -23.13 -23.13 -398.04 -38.68 -31.25
Capital Expenditure Coverage Ratio
 -23.13 -23.13 -398.04 -38.68 -31.25
Operating Cash Flow Coverage Ratio
 -23.37 -23.37 -39.46 -17.28 -37.43
Operating Cash Flow to Sales Ratio
 -1.34 -1.34 -1.81 -1.28 -4.49
Free Cash Flow Yield
-9.59%-7.86%-37.34%-10.72%-16.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 37.53 45.77 -2.40 -6.53 -7.50
Price-to-Sales (P/S) Ratio
 14.54 17.73 4.86 12.22 28.90
Price-to-Book (P/B) Ratio
 3.86 4.71 4.59 5.87 3.98
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.43 -12.72 -2.68 -9.33 -6.24
Price-to-Operating Cash Flow Ratio
 -10.88 -13.27 -2.68 -9.57 -6.44
Price-to-Earnings Growth (PEG) Ratio
 0.23 -0.43 -0.22 0.52 -0.40
Price-to-Fair Value
 3.86 4.71 4.59 5.87 3.98
Enterprise Value Multiple
 -5.02 -6.27 -2.13 -6.09 -6.46
Enterprise Value
 22.02M 27.49M 21.57M 51.13M 64.97M
EV to EBITDA
 -5.02 -6.27 -2.13 -6.09 -6.46
EV to Sales
 12.85 16.04 4.27 11.18 27.04
EV to Free Cash Flow
 -9.22 -11.51 -2.35 -8.53 -5.84
EV to Operating Cash Flow
 -9.61 -12.00 -2.36 -8.75 -6.03
Tangible Book Value Per Share
 0.17 0.17 0.16 0.20 0.49
Shareholders’ Equity Per Share
 0.17 0.17 0.16 0.31 0.60
Tax and Other Ratios
Effective Tax Rate
 0.06 0.06 0.04 0.04 0.12
Revenue Per Share
 0.05 0.05 0.15 0.15 0.08
Net Income Per Share
 0.02 0.02 -0.31 -0.28 -0.32
Tax Burden
 0.67 0.67 0.96 0.96 0.88
Interest Burden
 -0.22 -0.22 1.00 1.00 1.01
Research & Development to Revenue
 1.57 1.57 0.60 1.31 3.58
SG&A to Revenue
 1.73 1.73 1.22 1.95 2.31
Stock-Based Compensation to Revenue
 0.00 0.00 0.03 0.14 0.21
Income Quality
 -2.46 -2.46 0.86 0.68 1.02
Currency in GBP